Credibility crunch

From mobility aids to health trackers, robotics, gene editing and AI, the medical technology industry (MedTech) is overflowing with opportunity. Several macro trends point in its favour – an ageing population, rapid adoption of new technologies, and growing access to healthcare worldwide.

One thing remains consistent for growth in this sector: the power of a strong reputation, credibility, and clarity of purpose. This crucial trifecta is critical to win over customers, investors, and patients alike.

The later pandemic years were hard on the biotechnology industry. As inflation rose and costs spiraled, investors shied away, M&A activity tumbled, jobs were cut, and projects shelved. But in the last 12 months, biotech’s outlook has improved considerably.

Rapid technological advancements and groundbreaking innovations – from artificial intelligence to RNA technologies, genetic engineering, and bioprinting – are transforming the sector. This robust innovation pipeline paints a bright picture of the industry’s long-term future, and that’s attracting positive attention.

Clarity of brand, purpose and a strong vision for the future all have critical roles to play.

The top three challenges faced by MedTech firms:

Exploring the top three challenges faced by BioTech firms:

1

Building credibility in the market

MedTech is a highly specialized market already dominated by legacy players. To compete, startups must establish legitimacy with a robust corporate brand, underpinned by a clear and tangible purpose.

1

Attracting outside investment

The outlook for the biotechnology industry looks better than it has in years. Investors are showing renewed interest, but they remain cautious. Reputation, credibility, and a clear path to growth will
be critical.

2

Fending off the competition

Large MedTech companies have their own problems – they have been struggling with growth, a challenging M&A market, and stagnant valuations. Established players must exploit their reputation and scale to keep the growing competition at bay, while optimizing synergies within their portfolios.

2

M&A

M&A is also on the rise. Are businesses set up effectively to take advantage of potential opportunity?

3

The talent crisis

Big or small, MedTech firms are grappling with a shortage of specialized talent. To attract, engage and retain staff, businesses must motivate and unite their workforce with a sense of meaning and direction.

3

Setting up to win

In an environment of such rapid and transformative change, biotech firms need clarity of direction and a clearly defined positioning to attract investors and buyers alike.

See our work

See our work